annual retained earnings:
-$558.57M-$241.60M(-76.22%)Summary
- As of today (May 29, 2025), NAMS annual retained earnings is -$558.57 million, with the most recent change of -$241.60 million (-76.22%) on December 31, 2024.
- During the last 3 years, NAMS annual retained earnings has fallen by -$519.31 million (-1322.72%).
- NAMS annual retained earnings is now -7373.12% below its all-time high of -$7.47 million, reached on December 1, 2020.
Performance
NAMS Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$598.10M-$39.53M(-7.08%)Summary
- As of today (May 29, 2025), NAMS quarterly retained earnings is -$598.10 million, with the most recent change of -$39.53 million (-7.08%) on March 31, 2025.
- Over the past year, NAMS quarterly retained earnings has dropped by -$187.36 million (-45.61%).
- NAMS quarterly retained earnings is now -2986.35% below its all-time high of $20.72 million, reached on June 30, 2022.
Performance
NAMS quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NAMS Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.2% | -45.6% |
| 3 y3 years | -1322.7% | -2986.3% |
| 5 y5 years | -7373.1% | -1423.4% |
NAMS Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1322.7% | at low | -2986.3% | at low |
| 5 y | 5-year | -7373.1% | at low | -2986.3% | at low |
| alltime | all time | -7373.1% | at low | -2986.3% | at low |
NAMS Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$598.10M(+7.1%) |
| Dec 2024 | -$558.57M(+76.2%) | -$558.57M(+19.8%) |
| Sep 2024 | - | -$466.39M(+3.7%) |
| Jun 2024 | - | -$449.75M(+9.5%) |
| Mar 2024 | - | -$410.74M(+29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$316.97M(+126.4%) | -$316.97M(+50.0%) |
| Jun 2023 | - | -$211.33M(+50.9%) |
| Dec 2022 | -$140.04M(+256.7%) | -$140.04M(-775.8%) |
| Jun 2022 | - | $20.72M(-152.8%) |
| Dec 2021 | -$39.26M(+425.3%) | -$39.26M |
| Dec 2020 | -$7.47M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual retained earnings?
- What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings?
- What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
What is NewAmsterdam Pharma Company NV annual retained earnings?
The current annual retained earnings of NAMS is -$558.57M
What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual retained earnings is -$7.47M
What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
Over the past year, NAMS annual retained earnings has changed by -$241.60M (-76.22%)
What is NewAmsterdam Pharma Company NV quarterly retained earnings?
The current quarterly retained earnings of NAMS is -$598.10M
What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly retained earnings is $20.72M
What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
Over the past year, NAMS quarterly retained earnings has changed by -$187.36M (-45.61%)